Massachusetts Drugmaker Called Out for Conformity Testing

Drug Industry Daily
A A
The FDA slapped Watertown, Massachusetts, drug manufacturer pSivida with a Form 483 after inspectors found that the facility lacked defined procedures to ensure drug uniformity and homogeneity.

To View This Article:

Login

Subscribe To Drug Industry Daily